ArticleNuclear medicine communications2019

Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model.

Usman Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.